Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction

Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction

Background Dyslipidemia is common in heart failure with preserved ejection fraction. Sacubitril/valsartan improves glycemic control and augments natriuretic peptide signaling, providing mechanisms by which sacubitril/valsartan may affect serum lipids. However, empiric data on these effects are lacki...

Full description

Bibliographic Details
Main Authors: Senthil Selvaraj, Brian L. Claggett, Milton Packer, Faiez Zannad, Inder S. Anand, Burkert Pieske, Ziqiang Zhao, Victor C. Shi, Martin P. Lefkowitz, John J. V. McMurray, Scott D. Solomon
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
heart failure with preserved ejection fraction
lipids
metabolism
sacubitril/valsartan
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.022069

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.022069

Similar Items